These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1009684

  • 1. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
    Amlot PL, Unger A.
    Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
    [Abstract] [Full Text] [Related]

  • 2. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A, Pees H, Girmann G.
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [Abstract] [Full Text] [Related]

  • 3. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM, Huang AT, Kremer WB.
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [Abstract] [Full Text] [Related]

  • 4. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P, Velardi A, Spinozzi F, Falini B, Martelli MF.
    Boll Ist Sieroter Milan; 1979 Mar 31; 58(1):90-9. PubMed ID: 552840
    [Abstract] [Full Text] [Related]

  • 5. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ, Hansen JA, Bloomfield CD, Good RA.
    J Clin Invest; 1973 Dec 31; 52(12):3064-73. PubMed ID: 4201499
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H, Vogt W, Rühl U.
    G Batteriol Virol Immunol; 1975 Dec 31; 68(1-6):3-16. PubMed ID: 128484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
    Lang JM, Oberling F, Bigel P, Mayer S, Waitz R.
    Biomedicine; 1974 Sep 20; 21(9):372-7. PubMed ID: 4281669
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hodgkin's disease: response of lymphocytes to PHA.
    Sforza MB, De Somoza N, Morgenfeld CM.
    Sangre (Barc); 1971 Sep 20; 16(3):300-4. PubMed ID: 5120513
    [No Abstract] [Full Text] [Related]

  • 15. The lymphocyte response in Hodgkin's disease.
    Braeman J, Evans IH, Deeley TJ.
    Clin Radiol; 1975 Jul 20; 26(3):305-9. PubMed ID: 1081440
    [Abstract] [Full Text] [Related]

  • 16. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z, Strober S, King DP, Kaplan HS.
    J Immunol; 1976 Oct 20; 117(4):1331-5. PubMed ID: 1086325
    [Abstract] [Full Text] [Related]

  • 17. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease].
    Eggerth G, Kühböck J, Pokorny D.
    Wien Z Inn Med; 1969 Oct 20; 50(7):314-9. PubMed ID: 5380683
    [No Abstract] [Full Text] [Related]

  • 18. Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease.
    Sugden PJ, Lilleyman JS.
    Cancer; 1980 Mar 01; 45(5):899-905. PubMed ID: 7260841
    [Abstract] [Full Text] [Related]

  • 19. Abnormal lymphocyte responses in residents of a town with a cluster of Hodgkin's disease.
    Plouffe JF, Silva J, Schwartz RS, Callen JP, Kane P, Murphy LA, Goldstein IJ, Fekety R.
    Clin Exp Immunol; 1979 Feb 01; 35(2):163-70. PubMed ID: 436334
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
    Rühl H, Vogt W, Bochert G, Schmidt S, Schaoua H, Moelle R.
    Clin Exp Immunol; 1974 Jul 01; 17(3):407-15. PubMed ID: 4468860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.